{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:36:43Z","timestamp":1648856203212},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141872","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T19:18:37Z","timestamp":1446664717000},"page":"e0141872","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis"],"prefix":"10.1371","volume":"10","author":[{"given":"Javier M.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres F.","family":"Zuluaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Vesga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"H Wisplinghoff","year":"2004","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"Suppl. 1","key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1439-0507.2011.02151.x","article-title":"Invasive Candida infections in the ICU","volume":"55","author":"P Eggimann","year":"2012","journal-title":"Mycoses"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"PG Pappas","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"MC Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004\u20132008","volume":"74","author":"M Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref6","unstructured":"Richardson K. Antifungal 1,3-bis-triazolyl-2-propanol derivative. Patent 4,404,216. United States Patent and Trademark Office; 1983."},{"issue":"9247","key":"ref7","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/S0140-6736(05)74314-2","article-title":"Access to fluconazole in less-developed countries","volume":"356","author":"C Perez-Casas","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"e10744","DOI":"10.1371\/journal.pone.0010744","article-title":"Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model","volume":"5","author":"AF Zuluaga","year":"2010","journal-title":"PloS one"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.01044-09","article-title":"Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator","volume":"54","author":"O Vesga","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/AAC.00350-13","article-title":"Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem","volume":"58","author":"M Agudelo","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jinf.2009.08.005","article-title":"Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia","volume":"59","author":"CA Rodriguez","year":"2009","journal-title":"The Journal of infection"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jinf.2007.09.011","article-title":"Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime","volume":"56","author":"E Mastoraki","year":"2008","journal-title":"The Journal of infection"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.06012-11","article-title":"Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole","volume":"56","author":"M Agudelo","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/AAC.03633-14","article-title":"Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin","volume":"59","author":"CA Rodriguez","year":"2015","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/AAC.49.4.1642-1645.2005","article-title":"Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis","volume":"49","author":"V Petraitis","year":"2005","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"Suppl 4","key":"ref16","first-page":"S167","article-title":"A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis","volume":"88","author":"S Hoharitanon","year":"2005","journal-title":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5414\/CPP38355","article-title":"Pharmacokinetics and bioequivalence testing of generic fluconazole preparations in healthy thai volunteers","volume":"38","author":"M Manorot","year":"2000","journal-title":"International journal of clinical pharmacology and therapeutics"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.clinthera.2005.10.016","article-title":"A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers","volume":"27","author":"D Jovanovic","year":"2005","journal-title":"Clinical therapeutics"},{"key":"ref19","article-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"JM Gonzalez","year":"2012"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/IAI.56.11.2884-2890.1988","article-title":"Role of yeast cell growth temperature on Candida albicans virulence in mice","volume":"56","author":"PP Antley","year":"1988","journal-title":"Infection and immunity"},{"key":"ref21","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A3","year":"2008"},{"key":"ref22","first-page":"111","article-title":"Use of an animal model of disseminated candidiasis in the evaluation of antifungal therapy","volume":"118","author":"D Andes","year":"2005","journal-title":"Methods in molecular medicine"},{"key":"ref23","first-page":"115","article-title":"Fundaci\u00f3n del primerio bioterio MPF funcional de Colombia","volume":"16","author":"AF Zuluaga","year":"2010","journal-title":"IATREIA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-6-55","article-title":"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases","volume":"6","author":"AF Zuluaga","year":"2006","journal-title":"BMC infectious diseases"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12929-015-0124-4","article-title":"A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice","volume":"22","author":"AF Zuluaga","year":"2015","journal-title":"J Biomed Sci"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1208\/s12248-011-9257-x","article-title":"Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT","volume":"13","author":"JB Bulitta","year":"2011","journal-title":"The AAPS journal"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/cid\/ciu306","article-title":"About the validation of animal models to study the pharmacodynamics of generic antimicrobials","volume":"59","author":"AF Zuluaga","year":"2014","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref28","unstructured":"D&apos;Argenio DZ, Schumitzky A, Wang X. ADAPT 5 User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software.2009."},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.28.5.648","article-title":"Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans","volume":"28","author":"MJ Humphrey","year":"1985","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref30","first-page":"949","article-title":"Primer of applied regression &amp; analysis of variance","volume":"xxvii","author":"SA Glantz","year":"2001"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"M Valerio","year":"2014","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jac\/dkl241","article-title":"Effect of fluconazole consumption on long-term trends in candidal ecology","volume":"58","author":"S Blot","year":"2006","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref33","unstructured":"Number, rate, and average length of stay for discharges from short-stay hospitals, by age, region, and sex: United States, 2010 [Internet]. Centers for Disease Control and Prevention. 2010. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/nchs\/fastats\/hospital.htm\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/nchs\/fastats\/hospital.htm<\/ext-link>."},{"issue":"Database issue","key":"ref34","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"DS Wishart","year":"2006","journal-title":"Nucleic acids research"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2014.10.014","article-title":"Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin\/tazobactam","volume":"45","author":"M Agudelo","year":"2015","journal-title":"International journal of antimicrobial agents"},{"key":"ref36","article-title":"51<sup>st<\/sup> Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"M Agudelo","year":"2011"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1638\/2013-0042R1.1","article-title":"Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet&apos;s parrot (Psittrichas fulgidus)","volume":"45","author":"CM Molter","year":"2014","journal-title":"Journal of zoo and wildlife medicine: official publication of the American Association of Zoo Veterinarians"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/AAC.05344-11","article-title":"Product quality of parenteral vancomycin products in the United States","volume":"56","author":"S Nambiar","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.00164-12","article-title":"Quality assessment of U.S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays","volume":"56","author":"ME Hadwiger","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2146\/ajhp130516","article-title":"Comparison of three generic vancomycin products using liquid chromatography-mass spectrometry and an online tool","volume":"71","author":"PO Lewis","year":"2014","journal-title":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists"},{"key":"ref41","article-title":"54<sup>th<\/sup> Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"M Agudelo","year":"2014"},{"issue":"23","key":"ref42","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"TK Kishimoto","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"17","key":"ref43","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1213978","article-title":"Fungal infections associated with contaminated methylprednisolone injections","volume":"369","author":"RM Smith","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1592\/phco.23.5.572.32209","article-title":"Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations","volume":"23","author":"JD Cleary","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1128\/AAC.00296-07","article-title":"Correlation of the MIC and dose\/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia","volume":"51","author":"JL Rodriguez-Tudela","year":"2007","journal-title":"Antimicrobial agents and chemotherapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:08:41Z","timestamp":1599779321000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141872"}},"subtitle":[],"editor":[{"given":"David R.","family":"Andes","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141872","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}